Ensign Peak Advisors »

Kymera Therapeutics shares owned by Ensign Peak Advisors

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Ensign Peak Advisors from 13F filings

Historical chart of Ensign Peak Advisors investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Ensign Peak Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.4M 95k 77.81
2025-09-30 $5.2M 92k 56.60
2025-06-30 $4.0M 92k 43.64
2023-09-30 $559k 40k 13.90
2023-06-30 $924k 40k 22.99
2023-03-31 $1.2M 40k 29.63
2022-12-31 $1.0M 40k 24.96
2022-09-30 $1.0M 48k 21.77
2022-06-30 $914k 46k 19.69
2022-03-31 $2.5M 59k 42.32
2021-12-31 $3.8M 59k 63.48
2021-09-30 $1.9M 33k 58.74
2021-06-30 $3.0M 63k 48.50
2021-03-31 $2.4M 63k 38.87
2020-12-31 $1.2M 20k 62.00
2020-09-30 $646k 20k 32.30